Isotechnika Pharma Inc IPHAF

questions

[antoninus]

who does this turn of events benefit, if anyone...?

what is lux' cash position? why did ulrich grau leave? was there a conflict of strategy at lux?

what is isa's cash position?

what is isa's burn rate?

where do things stand with transplant?

where do things stand with psoriasis?

where does paladin stand in all of this?

[cmcujo]

The Company, as at March 31, 2010, had $5.17 million in cash and cash equivalents, accounts receivable of $440,000 and accounts payable and accrued liabilities of $1.47 million. The Company believes it has sufficient cash resources to continue its current planned operations until at least the fourth quarter of 2010. The Company will need to raise additional cash in the future.Small delay no big

[BornReady1970]

Small delay???Back to .20 tomorrow? What planet do you live on? ISA clearly states it has cash til Q4 of 2010, and the Europe approval can't happen til Q1 2011 at best (if it is approved at all). Even the fastest NEW trial in the USA will take more than a year, plus time for NDA reapplication. ISA has no more assets, PERIOD. There is nothing to left to raise $$$ against.Only question remaining

[cmcujo]

Like I said Overreaction.  !!!  If FDA approves SP would have rocketed up, so what they delayed.  Whats the difference between the last month and now.  more patience.  Obviously they will partner up or find another way to raise some cash.  THIS IS A GROSS OVERREACTION!We havent learned anything new here just that we have to wait a bit more for FDA approval.  

[tcdrugs]

It would be helpful if they told us what kind of a trial is needed.I still find it hard to believe Lux did not know about this, or at least the possibility of this, some time ago.  It's a stretch to try and blame this one on ISA.  This is all Lux, and one would have to assume it had something to do with the departure of Ulrich Grau.  As for ISA, a complete takeover now is

[ChiChi3]

BornReady1970 is pretty much right.  It will take 1-2 years to do the trial and ask apply for FDA approval and the only way for ISA to continue beyond 2010 is for dillution or selling off future revenue potential.  Either way, it will make the last Paladin deal look extremely attractive by comparison. I might further suggest that there is something seriously wrong with Voclosporin

[antoninus]

anyone know where ulrich grau has gone to? I would love to hear him comment....mostly though, I agree with a few of the other posters....I am in favour of either a takeover, or new management and hope this is put to a vote. IF TX had progressed, and IF psoriasis had progressed, we would not be at the mercy of lux and the fda deciding our fate. Taking our eye off these indications and not